Anton-Babinski Syndrome

Anton syndrome—also called Anton-Babinski syndrome or visual anosognosia—is a rare neurological condition in which a person is cortically blind yet firmly (and often aggressively) denies being blind. In other words, the eyes, optic nerves, and pupillary reflexes are usually intact, but strokes, trauma, infection, or other insults have damaged the visual cortex in both occipital lobes. The brain’s “seeing machinery” no longer works, but higher-order areas that plan, talk, and reason are still active, so the patient fills the void with vivid confabulations (“I can see you holding up three fingers”). This apparent paradox—total loss of vision plus a complete lack of insight into that loss—is what makes Anton syndrome so striking and so diagnostically challenging. A 2024 systematic review of 72 published cases describes the condition as “an unusual form of anosognosia characterized by bilateral vision loss coupled with denial of blindness.” pubmed.ncbi.nlm.nih.gov

Anton syndrome—sometimes called visual anosognosia—is a rare condition in which a person is cortically blind (the visual parts of the brain no longer “see”) yet firmly denies any loss of vision and often invents vivid, but imaginary, descriptions of the world around them (confabulation). It most often follows injury to both occipital lobes, classically from stroke, but it can also appear after trauma, infection, tumors and other disorders that cut visual messages off from the brain’s visual cortex.ncbi.nlm.nih.goveyewiki.org

When both primary visual cortices (Brodmann area 17) are destroyed, incoming light signals stop reaching consciousness. But association areas in the parietal-temporal-frontal network—regions that normally interpret, label, and narrate what we see—remain intact. They continue to generate an internal “storyline” of a sighted world, pulling scraps from memory, expectation, and imagination. Because real-time visual input is missing, the narrative becomes a confident but false reconstruction. This combination of cortical blindness plus confabulation equals Anton syndrome. StatPearls notes that disconnection between visual cortex and intact language networks is the leading explanatory theory. ncbi.nlm.nih.gov

• Seneca (1st century CE) described a slave who went blind overnight yet insisted the room was merely dark.

• Gabriel Anton (1895) presented patients who denied sensory deficits.

• Joseph Babinski (1914) coined the term anosognosia (“not-knowing of illness”).
  These classical descriptions still match modern case reports of stroke victims who walk unaided into walls while claiming to “see perfectly.” ncbi.nlm.nih.gov

---

Types of Anton Syndrome

Because the clinical core—cortical blindness plus denial—is constant, clinicians tend to classify Anton syndrome by underlying etiology rather than by separate clinical sub-types. Four broad patterns are useful:

1. Vascular Anton Syndrome — bilateral posterior cerebral artery (PCA) infarction or hemorrhage (the commonest scenario).

2. Traumatic Anton Syndrome — penetrating or closed-head injury damaging both occipital lobes.

3. Metabolic / Toxic / Infectious Anton Syndrome — e.g., hypoxic-ischemic encephalopathy after cardiac surgery, posterior reversible encephalopathy syndrome (PRES) in eclampsia or COVID-19, or progressive multifocal leukoencephalopathy in HIV.

4. Degenerative / Demyelinating Anton-like States — multiple sclerosis plaques, adrenoleukodystrophy, or mitochondrial disease (MELAS) causing bilateral visual-cortical destruction. ncbi.nlm.nih.gov

---

Evidence-Supported Causes

1. Bilateral PCA Ischemic Stroke
   Occlusion of both PCAs cuts blood flow to the visual cortices, abruptly producing blindness that the patient disowns. ncbi.nlm.nih.gov

2. Intracerebral Hemorrhage in the Occipital Lobes
   A bleed compresses and destroys visual tissue; denial often persists until swelling resolves.

3. Cardiac‐Bypass or Aortic Surgery
   Global hypoperfusion or emboli can infarct both occipital poles; postoperative confusion masks the deficit.

4. Cerebral Angiography Complications
   Iatrogenic emboli sometimes lodge bilaterally in distal PCAs, leading to sudden cortical blindness.

5. Head Trauma
   Contusions or diffuse axonal injury can selectively injure visual cortices while sparing language centers, fostering confabulation.

6. Posterior Reversible Encephalopathy Syndrome (PRES)
   Severe hypertension, eclampsia, or immunosuppressant toxicity produces vasogenic edema; if both occipital lobes swell, transient Anton syndrome may emerge.

7. Hypoxic-Ischemic Encephalopathy (Cardiac Arrest)
   The occipital lobes are oxygen-hungry; brief anoxia can cause laminar necrosis and permanent visual loss with denial.

8. Mitochondrial Encephalopathy (MELAS)
   Stroke-like metabolic episodes repeatedly damage posterior brain regions, resulting in stepwise cortical blindness.

9. Multiple Sclerosis (Fulminant Posterior Variant)
   Confluent demyelination can wipe out both visual cortices; denial appears when cognitive function is still relatively preserved.

10. Progressive Multifocal Leukoencephalopathy (HIV)
    JC-virus infections preferentially attack white matter, including optic radiations, causing visual anosognosia.

11. COVID-19 Associated Vasculitis
    Case reports link SARS-CoV-2 to bilateral occipital strokes and transient Anton syndrome.

12. Fat Embolism Syndrome
    After long-bone fractures, fat globules may obstruct both PCAs.

13. Systemic Lupus or CNS Vasculitis
    Immune-mediated vessel inflammation can create multifocal cortical infarcts.

14. Sickle-Cell Disease with Moyamoya Changes
    Recurrent vaso-occlusion of posterior circulation can culminate in blindness with denial.

15. Adrenoleukodystrophy
    X-linked peroxisomal dysfunction strips myelin, often beginning posteriorly; Anton syndrome appears in advanced stages.

16. Leukemic or Lymphomatous Infiltration
    Malignant cells infiltrate occipital cortices, gradually eroding vision unnoticed by the patient.

17. Radiation Necrosis (Post-Brain-Tumor Therapy)
    Months after occipital irradiation, necrotic cavitation may generate Anton syndrome.

18. Occipital Glioma or Metastasis
    Slow-growing tumors can destroy visual cortex with little awareness until both sides are affected.

19. Cerebral Amyloid Angiopathy
    Recurrent lobar micro-bleeds cumulatively impair visual cortices, leading to denial of progressive blindness.

20. Drug-Induced Posterior Cortical Toxicity (e.g., Cyclosporine)
    Immunosuppressants may precipitate PRES-like edema and transient cortical blindness with denial. pubmed.ncbi.nlm.nih.govpmc.ncbi.nlm.nih.gov

---

Symptoms

1. Complete Loss of Conscious Vision — the person cannot truly see, even though pupils react normally.

2. Firm Denial of Blindness (Anosognosia) — patient insists vision is normal.

3. Confabulation — vivid but fabricated descriptions of surroundings.

4. Misreaching or Bumping into Objects — walks into furniture or walls while claiming “the hallway shifted.”

5. Absent Threat Blink — no reflex blink when an object suddenly approaches the eyes.

6. Normal Pupillary Light Reflexes — pupils constrict to light, misleading observers into thinking eyes work.

7. Disorientation in New Environments — confusion when spatial cues rely on vision.

8. Visual Hallucinations — sometimes elaborate scenes fill the sensory void.

9. Perseveration of Visual Memories — describes previous room layout rather than current reality.

10. Riddoch Phenomenon — rare perception of fast-moving objects despite overall blindness.

11. Intact Color Naming — can recite color names yet cannot perceive them.

12. Verbal Agitation When Challenged — anger or frustration if told they are blind.

13. Memory Errors — mixing past and present visual scenes.

14. Hemiparesis or Hemisensory Loss — if stroke extends beyond occipital lobes.

15. Visual Neglect — ignores one half of imagined visual field.

16. Head Turning or Scanning Movements — compensatory but ineffective strategies to “find” objects.

17. Light/Shadow Misinterpretation — claims flickering shadows are moving animals.

18. Anxiety or Restlessness — arises when internal narrative clashes with external feedback.

19. Sleep Disturbance — vivid confabulatory dreams bleed into wakefulness.

20. Depression or Apathy (Late) — insight may eventually dawn, causing grief over permanent blindness. pubmed.ncbi.nlm.nih.govncbi.nlm.nih.gov

---

Diagnostic Tests and How Each Helps

Physical-Examination Procedures

1. Confrontation Visual-Field Testing — waving fingers in each quadrant shows absent fields despite claimed vision.

2. Pupillary Light Reflex Assessment — normal constriction confirms the lesion lies behind the optic tracts.

3. Blink-to-Threat Test — absent blink while eyes appear to track examiner by head turn alone.

4. Fundoscopy — healthy optic discs rule out ocular causes.

5. Swinging-Flashlight Test — brisk, symmetric response supports retro-ocular lesion.

6. Ocular Motility and Alignment — normal extraocular movements differentiate cortical from ocular motor palsies.

7. Neurological Gait Observation — bumping into obstacles documents functional blindness clinically.

8. Cognitive Insight Interview — structured questioning exposes denial and confabulation patterns. ncbi.nlm.nih.gov

Manual / Bedside Tests

9. Snellen Chart Attempt — patient guesses or reads memorized letters, revealing inconsistency.

10. Ishihara Color Plates — declares “all numbers are clear” despite inability to see them.

11. Mirror Self-Recognition — cannot track own reflection yet insists it looks “fine.”

12. Clock-Drawing Test — draws wild, spatially disorganized clock while denying difficulty.

13. Visual-Object Naming Flashcards — calls every shape “circle” or “dog,” then rationalizes errors.

14. Saccadic Eye-Movement Tracking — electro-oculography shows random scanning unlinked to stimuli.

15. Visual-Comparison Task — asked which of two cards is brighter; answers at chance level.

16. Blind-Spot Mapping with Red Pin — perceives none, demonstrating total field loss.

Laboratory & Pathological Tests

17. Complete Blood Count and Coagulation Panel — screens for anemia, clotting disorders predisposing to stroke.

18. Metabolic Panel — detects hypoglycemia or electrolyte shifts that exacerbate encephalopathy.

19. Serum Lactate and Genetic Testing — suggests MELAS when elevated.

20. Autoimmune Antibody Panel — ANA, ANCA, antiphospholipid antibodies for vasculitis-related strokes.

21. Inflammatory Markers (CRP, ESR) — support active vasculitis or infection.

22. Lipid Profile — identifies atherothrombotic risk factors.

23. Cerebrospinal Fluid Analysis — oligoclonal bands in multiple sclerosis or JC-virus PCR in PML.

24. Hypercoagulability Work-Up — Factor V Leiden, prothrombin gene, protein C/S deficiency.

Electrodiagnostic Tests

25. Visual Evoked Potentials (VEPs) — flat or absent cortical response despite normal retinal transmission.

26. Electroretinography (ERG) — preserves normal retinal function, localizing lesion to cortex.

27. Electroencephalography (EEG) — may show bilateral occipital slowing or alpha coma pattern post-anoxia.

28. Brainstem Auditory Evoked Potentials (BAEPs) — normal, assisting differential between Anton and cortical deafness.

29. Somatosensory Evoked Potentials (SSEPs) — assess coexistence of large infarcts affecting sensory pathways.

30. Transcranial Doppler Ultrasound — detects reduced PCA velocity or micro-embolic signals.

31. Ambulatory Blood-Pressure Monitoring — uncovers malignant hypertension triggering PRES.

32. Holter ECG — atrial fibrillation identification guides secondary stroke prevention.

Imaging Tests

33. Magnetic Resonance Imaging (MRI) with DWI/FLAIR — gold standard; bright bilateral occipital lesions confirm cortical injury.

34. Magnetic Resonance Angiography (MRA) — visualizes PCA occlusion or vasculitis.

35. Computed Tomography (CT) Brain — quick survey for bilateral occipital hemorrhage or large infarcts.

36. CT Angiography — detects thrombus in PCAs and major branches.

37. Oxygen-Positron Emission Tomography (PET) — shows occipital hypometabolism versus parietal-frontal hyper-activity.

38. Functional MRI (fMRI) — absent visual cortex activation alongside normal auditory activation during tasks.

39. Diffusion Tensor Imaging (DTI) — maps disrupted optic radiations.

40. Optical Coherence Tomography (OCT) of Retinal Nerve Fiber Layer — usually normal, helping prove a purely cortical lesion. sciencedirect.comsciencedirect.com

Non-Pharmacological Therapies

(Physiotherapy–Electrotherapy–Exercise Approaches, Mind-Body & Educational Strategies)

1. Vision Restoration Therapy (VRT) – computer-guided flashing-light stimulation that trains residual visual cortex to respond; performed 30 min twice daily for 6 months. Mechanism: repetitive sensory activation drives neuroplastic rewiring of peristriate areas.pmc.ncbi.nlm.nih.govresearchgate.net

2. Saccadic Compensation Training – therapist-led eye-movement drills teach rapid scanning toward blind field, improving navigation.

3. Prismatic Field Expansion Glasses – high-diopter prisms shift peripheral images into intact retina, compensating for blind zones.

4. Sensory-Substitution Devices (e.g., EyeCane, vOICe) – convert visual contrast into auditory or tactile cues the brain learns to decode.

5. Virtual-Reality (VR) Orientation Suites – immersive 3-D environments with haptic feedback safely rehearse way-finding.

6. Mirror‐Therapy-Inspired Hand-Eye Tasks – hands perform tasks in mirror view to co-activate motor and visual cortex.

7. Computerised Motion-Discrimination Games – optic-flow stimuli strengthen dorsal pathway connections.

8. Balance & Gait Training – physiotherapists focus on wide-based stance, proprioceptive cues, and vestibular input.

9. Low-Vision Aids & Magnifiers – enlarge text/images for any spared islands of vision.

10. Environmental Modification – high-contrast edging on doorways, decluttering floors, installing tactile guide strips.

11. Transcranial Direct-Current Stimulation (tDCS) – low-amp current over occipital scalp to potentiate plasticity during VRT sessions (research setting).frontiersin.org

12. Constraint-Induced Visual Training – patching the intact visual hemifield to force use of impaired field.

13. Vestibular Rehabilitation – dynamic head-eye coordination exercises.

14. Eye–Hand Coordination Drills – reaching toward targets with auditory prompts.

15. Strength & Endurance Exercises – supervised aerobic training improves cerebral perfusion and mood.

Mind-Body / Educational Self-Management 

16. Occupational Therapy for Activities of Daily Living (ADL) – kitchen safety, personal grooming, adaptive tech.

17. Orientation & Mobility (O&M) Cane Skills – structured white-cane techniques.

18. Cognitive-Behavioural Therapy (CBT) – addresses denial, depression, and anxiety.

19. Mindfulness-Based Stress Reduction (MBSR) – 8-week breathing and body-scan program lowers stress hormones.

20. Guided Imagery & Meditation – builds non-visual spatial maps.

21. Psycho-Education of Patient & Family – understanding blindness and anosognosia reduces conflict.

22. Peer-Support Groups – sharing strategies normalises experience.

23. Music Therapy – rhythmic cues assist locomotion and neuroplasticity.

24. Art & Clay Modelling – tactile creativity stimulates parietal integration.

25. Sleep-Hygiene Coaching – regular circadian cues improve cognitive recovery.

26. Memory Strategy Training – mnemonic devices and audio reminders.

27. Assistive Technology Training – screen-readers, smart-home voice assistants.

28. Caregiver Skill-Building Workshops – safe transfers, medication administration.

29. Nutrition Counselling – brain-healthy diet rich in omega-3 and antioxidants.

30. Fall-Prevention Home Assessment – occupational therapist checks lighting, removes tripping hazards.

These interventions work synergistically: sensorimotor exercises promote cortical rewiring, while psychological and educational tools build insight, coping, and independence.pmc.ncbi.nlm.nih.gov

---

Evidence-Based Drugs

Because Anton syndrome is secondary to brain damage, medication targets the underlying cause and stroke risk factors:

1. Alteplase (tPA) – 0.9 mg/kg IV (10 % bolus, rest over 60 min) within 4.5 h of ischemic stroke; class: thrombolytic; risk: intracranial bleeding.

2. Aspirin – 160–325 mg orally within 24–48 h of stroke, then 81 mg/day for maintenance; class: antiplatelet; risk: GI bleeding, gastritis.mayoclinic.orgaafp.org

3. Clopidogrel – 300 mg loading then 75 mg/day; class: P2Y12 inhibitor; risk: dyspepsia, bruising.

4. Dipyridamole + Aspirin (Aggrenox) – 25/200 mg twice daily; class: dual antiplatelet.

5. Apixaban – 5 mg twice daily for atrial-fibrillation-related emboli; class: NOAC; risk: bleeding.

6. Warfarin – dose to keep INR 2-3; class: vitamin-K antagonist; risk: hemorrhage, interactions.

7. Atorvastatin – 40-80 mg nightly; class: high-intensity statin; lowers LDL, stabilises plaques; risk: myalgia, transaminase rise.nejm.orgahajournals.org

8. Lisinopril – 10–40 mg daily; ACE-inhibitor to control BP; risk: cough, hyper-kalaemia.

9. Amlodipine – 5–10 mg daily; calcium-channel blocker; risk: ankle swelling.

10. Metoprolol – 50–200 mg/day; beta-blocker; risk: bradycardia, fatigue.

11. Citicoline – 500–1000 mg oral/IV twice daily for 6 weeks; class: neuroprotective; improves membrane repair; minimal side-effects (rare insomnia).

12. Piracetam – 1200 mg three times daily; nootropic; risk: agitation, weight gain.

13. Levetiracetam – 500–1500 mg twice daily for post-stroke seizures; class: anticonvulsant; risk: somnolence.

14. Sertraline – 50–100 mg daily; SSRI for post-stroke depression; risk: GI upset, sexual dysfunction.

15. Donepezil – 5–10 mg nightly; acetylcholinesterase inhibitor; aids cognition; risk: diarrhoea, vivid dreams.

16. Memantine – 10 mg twice daily; NMDA antagonist; risk: dizziness.

17. Baclofen – 5–20 mg TID; antispasticity; risk: sedation.

18. Gabapentin – 300–900 mg TID; neuropathic pain; risk: ataxia.

19. Tranexamic acid – 1 g IV/8 h in hemorrhagic stroke; antifibrinolytic; risk: thrombosis.

20. Nicardipine IV infusion – titrate to target BP in hypertensive emergencies; risk: reflex tachycardia.

Always individualise dosage to age, renal/hepatic function, and drug–drug interactions.

---

Dietary Molecular Supplements

1. Omega-3 DHA/EPA – 1000 mg/day; reduces neuro-inflammation; supports neuronal membrane integrity.

2. Curcumin (Turmeric extract) – 500 mg twice daily with pepperine; anti-oxidant, down-regulates NF-κB.

3. Resveratrol – 150 mg/day; activates SIRT-1 pathways for neuroprotection.

4. Lutein + Zeaxanthin – 10/2 mg daily; carotenoids concentrate in visual cortex.

5. Coenzyme Q10 – 200 mg/day; boosts mitochondrial ATP.

6. Alpha-Lipoic Acid – 300 mg/day; free-radical scavenger, regenerates other anti-oxidants.

7. Vitamin D3 – 2000 IU/day (adjust to serum 25-OH D); modulates neuro-immune responses.

8. Magnesium Citrate – 400 mg elemental/day; stabilises NMDA receptors, relaxes vessels.

9. Ginkgo biloba extract (EGb-761) – 120 mg/day; enhances micro-circulation and cognitive function.

10. B-Complex (B6, B9, B12) – lowers homocysteine, a stroke risk factor.

---

Specialised / Regenerative Drug Therapies

1. Etidronate (Bisphosphonate) – 400 mg/day cyclic; experimental use to prevent vascular calcification in chronic kidney disease and stroke-calcified arteries; acts on hydroxyapatite.

2. Alendronate – 70 mg weekly; similar investigational vascular benefits; inhibits osteoclast-like cells in arterial media.

3. Hyaluronic-Acid Viscosupplementation – intra-articular injections for post-stroke hemiplegic shoulder pain; provides joint lubrication.

4. Platelet-Rich Plasma (PRP) – ultrasound-guided soft-tissue injection for spastic muscle fibrosis; growth factors boost healing.

5. Erythropoietin (EPO) – 33 000 IU IV every 2 days ×3 doses in trials; anti-apoptotic via JAK2/STAT5.

6. N-Acetylcysteine (NAC) – 600 mg TID; precursor to glutathione, decreases oxidative stress.

7. Recombinant Human Nerve Growth Factor (Cenegermin) – off-label ocular drops studied for neurotrophic keratitis; extrapolated CNS repair.

8. MultiStem® Allogeneic Stem-Cell Infusion – 1–1.5 million cells/kg IV within 36 h of stroke; secretes anti-inflammatory cytokines.jamanetwork.com

9. Bone-Marrow-Derived MSCs – 0.5–2 million cells/kg IV in phase I trials for hemorrhagic stroke; promote angiogenesis, neurogenesis.pubmed.ncbi.nlm.nih.govmayoclinic.org

10. Exosome-Rich Stem-Cell Secretome – experimental intravenous nano-vesicles delivering miRNA cargo to injured cortex.

All regenerative therapies remain investigational; enrol only through accredited clinical trials.

---

Surgical or Interventional Procedures

1. Mechanical Thrombectomy – stent-retriever removal of large-vessel clot within 24 h to salvage occipital tissue.

2. Carotid Endarterectomy – removes atherosclerotic plaque, preventing emboli to posterior circulation.

3. Carotid / Vertebral Artery Stenting – percutaneous angioplasty with stent-graft for inaccessible lesions.

4. Decompressive Craniectomy – removes a skull flap to relieve malignant cerebral oedema post-infarct.

5. Occipital Tumor Resection – microsurgical or radiosurgical excision improves prognosis.

6. Aneurysm Clipping / Endovascular Coiling – prevents subarachnoid bleed that can cause cortical blindness.

7. Arteriovenous Malformation (AVM) Resection or Embolisation – eliminates haemorrhage risk.

8. Ventriculoperitoneal Shunt – treats hydrocephalus secondary to posterior fossa bleed.

9. Bypass Revascularisation (STA–PCA) – rare cerebrovascular-microsurgical graft for chronic PCA occlusion.

10. Cortical Visual Prosthesis Implant (experimental) – electrode arrays on visual cortex to create phosphenes.

Each procedure aims either to reverse the acute occlusion/bleed or prevent future events; benefits include better perfusion, reduced pressure and stabilised neural tissue.

Smart Prevention Strategies

1. Control blood pressure below 130/80 mm Hg.

2. Keep LDL-cholesterol < 70 mg/dL with diet and statins.

3. Quit tobacco and avoid second-hand smoke.

4. Limit alcohol to ≤ 2 drinks/day (men) or ≤ 1 (women).

5. Exercise 150 min of brisk walking weekly.

6. Maintain healthy body-mass index (BMI 18.5–24.9).

7. Treat atrial fibrillation with anticoagulants.

8. Manage diabetes (HbA1c < 7 %).

9. Wear helmets / seat-belts to prevent head injury.

10. Regular medical check-ups for early carotid or cardiac disease detection.

---

When Should You See a Doctor Immediately?

• Sudden dimming or total loss of vision in either eye.

• Bumping into objects, tripping, or inability to recognise faces.

• Persistent confusion about surroundings.

• Severe headache with nausea or weakness.

• Any new speech, balance or limb weakness issues.

Fast evaluation in an emergency department can save brain tissue and preserve residual sight.

---

Practical Do’s and Don’ts

Do

1. Use contrast tape on stair edges.

2. Install voice-activated assistants for daily tasks.

3. Practise guided walking with a sighted partner.

4. Keep walkways clutter-free.

5. Wear medical ID indicating cortical blindness.

Don’t
6. Drive or operate heavy machinery.
7. Assume “seeing” means safety—double-check hot stoves.
8. Ignore mood changes—seek counselling.
9. Hide the diagnosis from friends/family—education reduces accidents.
10. Skip medications or rehab sessions—consistency fuels brain plasticity.

---

Frequently Asked Questions

1. Can people with Anton syndrome ever regain sight?
   Possible if the underlying lesion is reversible (e.g., PRES) and intensive rehab is started early, but full recovery is rare.neurology.org

2. Why do patients deny blindness?
   Damage disconnects visual cortex from higher awareness centres, so the brain fills gaps with confabulation—it believes its own story.eyewiki.org

3. Is it the same as visual neglect?
   No; neglect is inattention to one side, while Anton involves total blindness plus denial.

4. How common is it?
   Extremely rare—seen in < 1 % of strokes because both occipital lobes must be affected.

5. What is the life expectancy?
   Depends on stroke severity and comorbidities, not the syndrome itself.

6. Are eyes themselves healthy?
   Yes, pupils react; the problem is inside the brain.

7. Does vitamin therapy cure it?
   Supplements aid overall brain health but cannot by themselves restore destroyed cortex.

8. Can children develop Anton syndrome?
   Very seldom, mostly after congenital malformations or severe trauma.

9. Will glasses help?
   Regular spectacles cannot fix cortical blindness, but prisms may expand usable field.

10. Can stem-cell therapy restore vision now?
    Still experimental; early trials show safety but no routine approval yet.pubmed.ncbi.nlm.nih.gov

11. Is depression inevitable?
    High risk exists; early counselling and social support are protective.

12. How long should rehab continue?
    Brain plasticity persists for years; many patients train indefinitely.

13. Do eyewitness hallucinations mean insanity?
    No—they are brain-generated “fill-ins” a blind person truly perceives.

14. What technology helps most?
    Screen readers, smart-phone voice assistants, GPS navigation with haptic feedback.

15. Could future visual prostheses bypass the damage?
    Research on cortical implants is promising, but widespread use is 5–10 years away.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: June 21, 2025.